老年慢性心功能不全合并房颤患者应用阿托伐他汀的临床分析被引量：8

下载PDF

导出

摘要炎症在心功能不全和房颤(AF)的发生、发展中起着重要作用。本文旨在探讨阿托伐他汀对老年慢性心功能不全合并阵发性AF患者炎症水平及临床预后的影响。1方法：.1研究对象2009年3月至2011年3月连续住院治疗的慢性心功能不全伴阵发性AF患者169例,随机分为阿托伐他汀组89例,其中男47例、女42例,平均年龄(63.9±8.9)岁,其中冠心病58例,高血压心脏病19例,扩张性心肌病12例。

作者龚和禾

机构地区南京医科大学附属南京医院老年科

出处《中国老年学杂志》 CAS CSCD 北大核心 2014年第18期5277-5278,共2页 Chinese Journal of Gerontology

关键词心房颤动慢性心功能不全阿托伐他汀

分类号 R541.6 [医药卫生—心血管疾病] R541.75 [医药卫生—心血管疾病]

引文网络
相关文献

参考文献4

1Madison S. Spach.Mounting Evidence That Fibrosis Generates a Major Mechanism for Atrial Fibrillation[J].Circulation Research.2007(8)
2Chung-Wah Siu,Chu-Pak Lau,Hung-Fat Tse.Prevention of atrial fibrillation recurrence by statin therapy in patients with lone atrial fibrillation after successful cardioversion[J].The American Journal of Cardiology.2003(11)
3Yenn-Jiang Lin,Hsuan-Ming Tsao,Shih-Lin Chang,Li-Wei Lo,Ta-Chuan Tuan,Yu-Feng Hu,Ameya R. Udyavar,Wen-Chin Tsai,Chien-Jung Chang,Ching-Tai Tai,Pi-Chang Lee,Kazuyoshi Suenari,Shih-Yu Huang,Nguyen Huu Tung,Shih-Ann Chen.Prognostic Implications of the High-Sensitive C-Reactive Protein in the Catheter Ablation of Atrial Fibrillation[J].The American Journal of Cardiology.2010(4)
4黎红,龙健猷,贾旭荣,韦诚,徐宗荣.缬沙坦和阿托伐他汀治疗高血压病合并持续性房颤的疗效观察[J].陕西医学杂志,2010,39(8):1057-1058. 被引量：11

二级参考文献11

1袁宇,苗润宏.心房颤动患者C-反应蛋白的表达及临床意义[J].陕西医学杂志,2008,37(12):1623-1624. 被引量：2
2孙晓红,彭晓玲,周莲英.血清高敏C反应蛋白与心房颤动[J].岭南心血管病杂志,2006,12(2):98-100. 被引量：21
3KinayO,Nazlic C,Ernene O,et al.Time interval from the initiation of the electrocardiographic P wave to the start of left atrial appendage ejection flow:A novel method for predicting atrial fibrillation recurrence[J].Am Soc Echocardiogr,2002,15:1479.
4Hideko N.Koickiro.K.Hidenori u et al,Angiotensin Ⅱ antagonsist prevents electrical,remodeling in atrial fibrillation[J].Circulation,2000,6:2 612.
5Van-den Berg MP,Crijns HJGM,Van-Vekihuisen DJ,et al.Effects of lisinopril in patients with heart failure and chronic atrial fibrillation[J].Card Fail,1995,1:355-364.
6Wachetll K,Lehto M,Gerdts E,et al.Angiotensin Ⅱ recep tor blockade reduces new-onset atrial fibrillation and subsequent stroke compared to atenolol:the Losartan Intervention for End Point Reduction in Hypertension (LIFE) study[J].J Am Coll Cardiol,2005,45(5):712-719.
7Madrid AH,Peng J,Zamora J,et al.The role of angiotensin receptor blockers and or angiotensin converting enzyme inhibitors in the prevention of atria fibrillation in patient with cardiovascular disease meta-analysis of randomized controlled clinical trials[J].Pacing Clin Electrophysiol,2004,27(10):1405-1410.
8ChungMK,Martin DO,Sprecher D,et al.C-reactive protein elevation in patients with atrial arrhythmias:inflammatory mechanisms and persistence of atrial fibrillation.Circulation,2001,104:2886-2891.
9Dernellis J,Panaretou M.Relationship between C-reactive protein concentrations during glucocorticoid therapy and recurrent atria fibrillation[J].Eur Heart J,2004,25(8):1100-1107.
10甘文云,唐其柱,王蕾,田青,周恒.高敏C反应蛋白在房颤中的意义及其与心功能的关系[J].实用医学杂志,2009,25(4):586-587. 被引量：10